These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20807507)

  • 1. Transmission of circulating cell-free AA amyloid oligomers in exosomes vectors via a prion-like mechanism.
    Tasaki M; Ueda M; Ochiai S; Tanabe Y; Murata S; Misumi Y; Su Y; Sun X; Shinriki S; Jono H; Shono M; Obayashi K; Ando Y
    Biochem Biophys Res Commun; 2010 Oct; 400(4):559-62. PubMed ID: 20807507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
    Westermark GT; Westermark P
    FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK506 inhibits murine AA amyloidosis: possible involvement of T cells in amyloidogenesis.
    Ueda M; Ando Y; Nakamura M; Yamashita T; Himeno S; Kim J; Sun X; Saito S; Tateishi T; Bergström J; Uchino M
    J Rheumatol; 2006 Nov; 33(11):2260-70. PubMed ID: 16981291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of amyloid-enhancing factor (AEF): study on experimental murine AA amyloidosis.
    Omoto M; Yokota T; Cui D; Hoshii Y; Kawano H; Gondo T; Ishihara T; Kanda T
    Med Mol Morphol; 2007 Jun; 40(2):88-94. PubMed ID: 17572844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid induction of experimental AA amyloidosis in mink by intravenous injection of amyloid enhancing factor.
    Sørby R; Espenes A; Landsverk T; Westermark G
    Amyloid; 2008 Mar; 15(1):20-8. PubMed ID: 18266118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review. Reflections on amyloidosis in Papua New Guinea.
    Westermark P; Westermark GT
    Philos Trans R Soc Lond B Biol Sci; 2008 Nov; 363(1510):3701-5. PubMed ID: 18849285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides.
    Liu Y; Cui D; Hoshii Y; Kawano H; Une Y; Gondo T; Ishihara T
    Scand J Immunol; 2007 Nov; 66(5):495-500. PubMed ID: 17953525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusible amyloid oligomers trigger systemic amyloidosis in mice.
    Senthilkumar S; Chang E; Jayakumar R
    Biochem J; 2008 Oct; 415(2):207-15. PubMed ID: 18564059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis.
    Mihara M; Shiina M; Nishimoto N; Yoshizaki K; Kishimoto T; Akamatsu K
    J Rheumatol; 2004 Jun; 31(6):1132-8. PubMed ID: 15170926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid enhancing factor-loaded macrophages in amyloid fibril formation.
    Shirahama T; Miura K; Ju ST; Kisilevsky R; Gruys E; Cohen AS
    Lab Invest; 1990 Jan; 62(1):61-8. PubMed ID: 2296158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission of systemic AA amyloidosis in animals.
    Murakami T; Ishiguro N; Higuchi K
    Vet Pathol; 2014 Mar; 51(2):363-71. PubMed ID: 24280941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmissibility of systemic amyloidosis by a prion-like mechanism.
    Lundmark K; Westermark GT; Nyström S; Murphy CL; Solomon A; Westermark P
    Proc Natl Acad Sci U S A; 2002 May; 99(10):6979-84. PubMed ID: 12011456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of ubiquitin to experimentally induced murine AA amyloid.
    Chronopoulos S; Alizadeh-Khiavi K; Normand J; Ali-Khan Z
    J Pathol; 1991 Mar; 163(3):199-203. PubMed ID: 1707449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion-like aggregates: infectious agents in human disease.
    Westermark GT; Westermark P
    Trends Mol Med; 2010 Nov; 16(11):501-7. PubMed ID: 20870462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils?
    Baltz ML; Rowe IF; Caspi D; Turnell WG; Pepys MB
    Clin Exp Immunol; 1986 Dec; 66(3):701-8. PubMed ID: 3105937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are elevated serum amyloid A levels and amyloid-enhancing factor sufficient to induce inflammation-associated amyloid deposition?
    Kisilevsky R; Tan R; Subrahmanyan L; Snow A
    Appl Pathol; 1984; 2(6):308-15. PubMed ID: 6400464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceleration of murine amyloidosis by implantation of amyloid-containing grafts.
    Ono S; Cui D; Kunitsugu I; Hoshii Y; Kawano H; Takahashi M; Gondo T; Ishihara T
    Amyloid; 2005 Dec; 12(4):226-32. PubMed ID: 16399647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular events associated with the initial phase of AA amyloidogenesis: insights from a human monocyte model.
    Magy N; Benson MD; Liepnieks JJ; Kluve-Beckerman B
    Amyloid; 2007 Mar; 14(1):51-63. PubMed ID: 17453625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E1 inhibition of experimental amyloidosis in CBA/J mice.
    Brandwein SR; Sipe JD; Skinner M; Cohen AS
    J Rheumatol; 1985 Jun; 12(3):418-26. PubMed ID: 4045840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.